It is revealed that though statistically not significant, GBM patients in EIF4E1B high expression group tend to have worse clinical outcomes (Figure 6G), however, in the LGG cohort, high EIF4E1B expression was significantly associated with better survival probability (Figure 6H). This evidence concerns the gene EIF4E1B and glioblastoma.